Seeing Is Believing

Currently out of the existing stock ratings of Emily Field, 27 are a BUY (57.45%), 12 are a HOLD (25.53%), 8 are a SELL (17.02%).
Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 47.62% that have a potential upside of 18.68% achieved within 236 days.
Emily Field’s has documented 85 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 03-Feb-2025.
Analyst best performing recommendations are on GLPG (GALAPAGOS NV ADR).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 3/2/2021. The price target of $82.77 was fulfilled within 1 day with a profit of $1.59 (1.88%) receiving and performance score of 18.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Aug-2025
$890
$118.47 (15.36%)
$925
3 days ago
(27-Feb-2026)
2/4 (50%)
$118.47 (15.36%)
42
Buy Since 29-Jul-2022
$940
$168.47 (21.84%)
$915
3 days ago
(27-Feb-2026)
33/34 (97.06%)
$168.47 (21.84%)
153
Buy Since 13-Sep-2018
$1247
$475.47 (61.63%)
$1317
3 days ago
(27-Feb-2026)
19/22 (86.36%)
$475.47 (61.63%)
198
Buy Since 28-Oct-2021
$1120
$348.47 (45.17%)
$1070
3 days ago
(27-Feb-2026)
12/16 (75%)
$348.47 (45.17%)
155
Buy Since 16-Nov-2017
$1000
$228.47 (29.61%)
$1000
1 months 16 days ago
(14-Jan-2026)
20/22 (90.91%)
$200.67 (25.10%)
119
What Year was the first public recommendation made by Emily Field?